Stockscreener 앱 받기
1.095
0.46%
0.005
시간 외 거래:
1.10
0.005
+0.46%
전일 마감가:
$1.09
열려 있는:
$1.1
하루 거래량:
49,866
Relative Volume:
0.42
시가총액:
$15.09M
수익:
-
순이익/손실:
$-17.93M
주가수익비율:
-0.6186
EPS:
-1.77
순현금흐름:
$-14.28M
1주 성능:
+15.42%
1개월 성능:
+7.35%
6개월 성능:
-27.96%
1년 성능:
-54.37%
1일 변동 폭
$1.08
$1.12
1주일 범위
$0.91
$1.12
52주 변동 폭
$0.90
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
명칭
Cocrystal Pharma Inc
전화
(786) 459-1831
주소
19805 N. CREEK PARKWAY, BOTHELL, WA
COCP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.095 | 15.02M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-07-08 | 개시 | H.C. Wainwright | Buy |
Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스
Phillip Md Et Al Frost Purchases 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock - Defense World
Buyback Watch: How analysts rate Cocrystal Pharma Inc stock todayBull Run & Weekly Watchlist for Hot Stocks - moha.gov.vn
Financial Survey: CytomX Therapeutics (NASDAQ:CTMX) versus Cocrystal Pharma (NASDAQ:COCP) - Defense World
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k By Investing.com - Investing.com Nigeria
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k - Investing.com
Aug Decliners: Will Cocrystal Pharma Inc. stock split attract more investors - moha.gov.vn
Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - Улправда
Why Cocrystal Pharma Inc. stock is a must watch in 2025Market Performance Summary & Safe Entry Momentum Stock Tips - Улправда
Rally Mode: Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reports2025 Trade Ideas & Safe Capital Growth Stock Tips - Улправда
Why Cocrystal Pharma Inc. (8CC) stock could be top winnerJuly 2025 Sentiment & High Conviction Investment Ideas - moha.gov.vn
Is Cocrystal Pharma Inc. stock a safe haven assetJuly 2025 Price Swings & AI Powered Market Entry Strategies - DonanımHaber
Will Cocrystal Pharma Inc. stock gain from government policiesMarket Volume Summary & Long-Term Capital Growth Ideas - bolumsonucanavari.com
Will Cocrystal Pharma Inc. stock split attract more investorsEarnings Overview Summary & Weekly High Potential Alerts - DonanımHaber
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial By Investing.com - Investing.com Australia
Should I hold or sell Cocrystal Pharma Inc. stock in 2025Market Growth Report & Long-Term Safe Return Strategies - Bölüm Sonu Canavarı
Can Cocrystal Pharma Inc. stock deliver strong Q4 earnings2025 EndofYear Setup & High Conviction Buy Zone Picks - DonanımHaber
Sentiment Recap: Why Cocrystal Pharma Inc. stock is a must watch in 2025Dip Buying & Short-Term High Return Ideas - Улправда
[8-K] Cocrystal Pharma, Inc. Reports Material Event | COCP SEC FilingForm 8-K - Stock Titan
Cocrystal Pharma, Inc. Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - marketscreener.com
Cocrystal Pharma (COCP) Set to Begin Norovirus Study with IRB Ap - GuruFocus
Cocrystal Pharma gains IRB approval for norovirus trial - TipRanks
Cocrystal Pharma Initiates Phase 1b Study for Norovirus Treatment - TradingView — Track All Markets
Cocrystal Pharma receives IRB approval from Emory University School of Medicine - marketscreener.com
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial - Investing.com
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - GlobeNewswire
Cocrystal Pharma (NASDAQ:COCP) Shares Down 3.5% – Here’s What Happened - Defense World
Cocrystal Pharma Earnings Notes - Trefis
EPS Watch: Can Cocrystal Pharma Inc. stock deliver strong Q4 earningsQuarterly Investment Review & Reliable Intraday Trade Alerts - moha.gov.vn
Portfolio Update: Is Cocrystal Pharma Inc stock trading near support levelsWeekly Investment Report & Low Risk Investment Opportunities - moha.gov.vn
Revenue per share of Cocrystal Pharma Inc – FWB:8CC - TradingView
Why institutional investors increase stakes in Cocrystal Pharma Inc. (8CC) stockJuly 2025 Review & AI Optimized Trade Strategies - Newser
Published on: 2025-12-02 05:48:00 - Newser
How Cocrystal Pharma Inc. (8CC) stock valuation compares with sectorBond Market & Reliable Price Breakout Signals - Newser
How Cocrystal Pharma Inc. (8CC) stock behaves under inflation pressureWeekly Market Summary & Weekly High Return Opportunities - Newser
Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Expert-Curated Trade Recommendations - Newser
Cocrystal Pharma to Present at Emerging Growth Conference - TipRanks
Cocrystal Pharma to Present at Noble Capital Markets Conference - TradingView
COCP Insider Trading - Quiver Quantitative
Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference - Quiver Quantitative
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference - marketscreener.com
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 - Investing.com
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 - Investing.com India
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 By Investing.com - Investing.com Australia
COCP insider Phillip Frost updates holdings after 20,000-share trade - Stock Titan
Cocrystal Pharma Inc (COCP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):